-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
-
Summary
-
Silexion Therapeutics Corp quarterly and annual Depreciation history and change rate from Q2 2023 to Q3 2025.
- Silexion Therapeutics Corp Depreciation for the quarter ending 30 Sep 2025 was $4,000, a 82% decline year-over-year.
- Silexion Therapeutics Corp Depreciation for the twelve months ending 30 Sep 2025 was $1,000.
- Silexion Therapeutics Corp annual Depreciation for 2024 was $25,000, a 44% decline from 2023.
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Change (%)
Depreciation, Annual (USD)
Depreciation, YoY Annual Change (%)